Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 22Cisplatin 17Surveys and Questionnaires 9Radiotherapy 8Carboplatin 8Radiotherapy, Intensity-Modulated 7Cetuximab 7Paclitaxel 6Nivolumab 6Drug Therapy 6Radiation 4Fluorouracil 4Taxes 3Docetaxel 3selpercatinib 2dostarlimab 2Yoga 2Surgical Procedures, Operative 2Standard of Care 2Radiosurgery 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Chemoradiotherapy 2Blood Specimen Collection 2ALX148 2veliparib 1tisotumab vedotin 1tislelizumab 1palbociclib 1osimertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Head and Neck Neoplasms × tisotumab vedotin × Clear all
NCT03485209 2026-04-20

innovaTV 207

Seagen Inc.

Phase 2 Active not recruiting
350 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡